Transl Clin Pharmacol.  2019 Mar;27(1):2-5. 10.12793/tcp.2019.27.1.2.

Expert clinical consulting for early drug development programs in Korea

• Moon H

• KMID: 2442239
• DOI: http://doi.org/10.12793/tcp.2019.27.1.2

Abstract

No abstract available.

MeSH Terms

Korea*

Figure

• 

  Figure 1 Specialists required throughout the drug development process.

• 

  Figure 2 Consulting process and timeline for the ACT program (courtesy of KoNECT).

Reference

1. Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov. 2010; 9:203–214. DOI: 10.1038/nrd3078. PMID: 20168317.

2. Moon H. Clinical Consulting for efficient and successful drug discovery. 2018. 7. https://www.konect.or.kr/Konect_Newsletter/files/12th/article2.pdf.

3. Chee D. Personal Communication. 2019.